Biogen (BIIB) volatility Up into 3Q revenues of $789m, BIIB evaluating better value for its stockholders
Tweet Send to a Friend
Biogen (Nasdaq: BIIB) : BIIB reported Q3 EPS of .58 cents verses consensus estimates of .65 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
